BerandaBEAM • BMV
add
Beam Therapeutics Inc
Tutup sebelumnya
$546,25
Rentang tahun
$356,51 - $590,00
Kapitalisasi pasar
2,19Â M USD
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 14,27Â jt | -17,01% |
Biaya operasional | 26,52Â jt | 4,35% |
Laba bersih | -96,67Â jt | -0,60% |
Margin laba bersih | -677,47 | -21,22% |
Penghasilan per saham | -1,17 | 4,10% |
EBITDA | -101,03Â jt | 1,99% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 925,76Â jt | -8,83% |
Total aset | 1,17Â M | -9,23% |
Total liabilitas | 380,05Â jt | -25,71% |
Total ekuitas | 791,32 jt | — |
Saham yang beredar | 79,59 jt | — |
Harga terhadap nilai buku | 54,79 | — |
Tingkat pengembalian aset | -21,89% | — |
Tingkat pengembalian modal | -26,99% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -96,67Â jt | -0,60% |
Kas dari operasi | -88,12Â jt | 1,85% |
Kas dari investasi | 24,70Â jt | 341,43% |
Kas dari pembiayaan | 1,26Â jt | -96,57% |
Perubahan kas bersih | -62,16Â jt | 1,70% |
Arus kas bebas | -42,99Â jt | -17,18% |
Tentang
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods. Wikipedia
CEO
Didirikan
2017
Situs
Karyawan
472
